Abnormal glucagon secretion in Zucker fatty rats

Area of Science:

• Endocrinology
• Metabolic Research
• Animal Models

Background:

• Zucker fatty rats are a common model for studying obesity and related metabolic dysfunctions.
• Glucagon secretion plays a critical role in glucose homeostasis and is regulated by various physiological stimuli.

Purpose of the Study:

• To investigate the responsiveness of glucagon secretion to different stimuli in Zucker fatty rats.
• To determine if glucagon secretion abnormalities in fatty rats are related to the fa gene or secondary to obesity.

Main Methods:

• Examined plasma glucagon and glucose levels in response to epinephrine, cold exposure, insulin, and arginine infusion in Zucker fatty and lean rats.
• Assessed the effects of streptozotocin (STZ) treatment on insulin and glucagon secretion in response to arginine.
• Compared responses in Zucker fatty rats with ventromedial hypothalamus-lesioned obese rats.

Main Results:

• Fatty rats showed similar glucagon increases to epinephrine and cold exposure as lean rats, but higher glucose responses.
• Glucagon secretion was blunted in response to insulin-induced hypoglycemia in fatty rats.
• Arginine infusion led to exaggerated glucagon and insulin secretion and higher glucose levels in fatty rats compared to lean rats.
• STZ treatment impaired insulin response but not exaggerated glucagon secretion in fatty rats, while it exaggerated glucagon secretion in lean rats.
• Ventromedial hypothalamus-lesioned obese rats mirrored the enhanced arginine-stimulated glucagon and insulin secretion seen in fatty rats.

Conclusions:

• Glucagon secretion in Zucker fatty rats appears unresponsive to the inhibitory effects of glucose and insulin.
• The observed A cell abnormalities in Zucker fatty rats are likely secondary to obesity rather than a direct effect of the fa gene.
• These findings highlight the complex regulation of glucagon secretion in the context of obesity.